Revvity

Update in progress

RVTY (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryDiagnostics & Research

Revvity, Inc. delivers health sciences solutions, instruments, reagents, software, and services for diagnostics, early detection, and genomic workflows. Its portfolio spans detection and imaging, assay platforms, and data tools for oncology, immunodiagnostics, and genetic testing. It serves pharma, labs, academia, and public health entities. Formerly PerkinElmer, renamed in 2023. Founded 1937; based in Waltham, MA.

Company score

Sentiment: 0.14; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.02; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.03; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.01; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.08; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive